Pacira Pharmaceuticals Achieves Favorable Resolution With FDA; Reaffirms Broad Indication for EXPAREL

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that it has achieved an amicable resolution with the United States in its ...